{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:37:16Z","timestamp":1790869036327,"version":"4.1.0"},"reference-count":190,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.virusres.2007.12.021","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T14:26:39Z","timestamp":1204899999000},"page":"104-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo"],"prefix":"10.1016","volume":"134","author":[{"given":"Javier","family":"Martinez-Picado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2007.12.021_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2005.10.016","article-title":"A novel small reporter gene and HIV-1 fitness assay","volume":"133","author":"Ali","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2007.12.021_bib2","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/00002030-200111230-00017","article-title":"Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/08892220260190308","article-title":"Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure","volume":"18","author":"Antinori","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2007.12.021_bib4","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1128\/JVI.74.18.8390-8401.2000","article-title":"Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture","volume":"74","author":"Archer","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00002030-200303280-00026","article-title":"Sorting out the complexities of HIV-1 fitness","volume":"17","author":"Arts","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib6","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","article-title":"Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme","volume":"15","author":"Back","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.virusres.2007.12.021_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.aids.0000199825.34241.49","article-title":"Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness","volume":"20","author":"Bangsberg","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11904-996-0006-1","article-title":"The role of viral fitness in HIV pathogenesis","volume":"2","author":"Barbour","year":"2005","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.virusres.2007.12.021_bib9","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1128\/JVI.76.21.11104-11112.2002","article-title":"Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults","volume":"76","author":"Barbour","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib10","first-page":"S80","article-title":"Wide variation in pro\/pol replication capacity in recently transmitted HIV-1 is conferred in part by protease inhibitor resistance mutations","volume":"7","author":"Barbour","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/01.aids.0000131391.91468.ff","article-title":"Persistence of primary drug resistance among recently HIV-1 infected adults","volume":"18","author":"Barbour","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/422036","article-title":"Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 Infection","volume":"190","author":"Barbour","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.10162","article-title":"Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors","volume":"68","author":"Belec","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/135965350601100208","article-title":"Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load","volume":"11","author":"Bezemer","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib15","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/JVI.75.7.3291-3300.2001","article-title":"Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1","volume":"75","author":"Bleiber","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib16","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1098\/rspb.2002.2097","article-title":"Procedures for reliable estimation of viral fitness from time-series data","volume":"269","author":"Bonhoeffer","year":"2002","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.virusres.2007.12.021_bib17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/JVI.76.4.1753-1761.2002","article-title":"Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection","volume":"76","author":"Brenner","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib18","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.aids.0000131377.28694.04","article-title":"Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection","volume":"18","author":"Brenner","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/135965359900400211","article-title":"Different outcome in the first two patients with an HIV-1 multinucleoside drug-resistant T69SSS insertion in Spain","volume":"4","author":"Briones","year":"1999","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-1702(99)00120-3","article-title":"Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy","volume":"66","author":"Briones","year":"2000","journal-title":"Virus Res."},{"key":"10.1016\/j.virusres.2007.12.021_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.2002.1520","article-title":"Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions","volume":"300","author":"Cabana","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib22","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1128\/JVI.77.22.12105-12112.2003","article-title":"Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma","volume":"77","author":"Campbell","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/01.aids.0000163943.31682.c8","article-title":"Can a K103N HIV strain stably overcome the wild type in the absence of non-nucleoside reverse transcriptase inhibitor selective pressure?","volume":"19","author":"Capetti","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.virusres.2007.12.021_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JVI.78.2.603-611.2004","article-title":"Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants","volume":"78","author":"Collins","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib26","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/JVI.02712-06","article-title":"The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions","volume":"81","author":"Cong","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib27","unstructured":"Daar, E.S., Frost, S.D.W., Wong, J.K., Hellmann, N.S., Wrin, T., Petropoulos, C.J., Richman, D.D., Pitt, J.A., Little, S.J., Leigh Brown, A.J., 2002. Mixed infection with multidrug resistant (MDR) and wild type HIV strains in primary HIV infection (PHI): early viral rebound suggests loss of immune control (Abstract 96). In: Proceedings of the 9th Conference on Retroviruses and Opportunistic Infections, February 24\u201328, 2002. Seattle, WA, USA, http:\/\/www.retroconference.org\/2002\/Abstract\/13158.htm."},{"key":"10.1016\/j.virusres.2007.12.021_bib28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1086\/516511","article-title":"Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy","volume":"176","author":"De Antoni","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-199901140-00010","article-title":"Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs","volume":"13","author":"de Jong","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JVI.75.2.595-602.2001","article-title":"Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus","volume":"75","author":"de Ronde","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1086\/315334","article-title":"Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection","volume":"181","author":"Deeks","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM200102153440702","article-title":"Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia","volume":"344","author":"Deeks","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/380098","article-title":"Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1","volume":"189","author":"Deeks","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib34","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/496892","article-title":"Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection","volume":"192","author":"Deeks","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib35","doi-asserted-by":"crossref","first-page":"25489","DOI":"10.1074\/jbc.M313534200","article-title":"A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions","volume":"279","author":"Deval","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2007.12.021_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1074\/jbc.M308806200","article-title":"Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations","volume":"279","author":"Deval","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2007.12.021_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jmv.2023","article-title":"Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations","volume":"65","author":"Devereux","year":"2001","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib38","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/AAC.46.7.2254-2256.2002","article-title":"Pressure of zidovudine accelerates the reversion of lamivudine resistance-conferring M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1","volume":"46","author":"Diallo","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib39","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1128\/JVI.77.16.8621-8632.2003","article-title":"Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity","volume":"77","author":"Diallo","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.micro.51.1.151","article-title":"RNA virus mutations and fitness for survival","volume":"51","author":"Domingo","year":"1997","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2007.12.021_bib41","series-title":"Origin and Evolution of Viruses","first-page":"141","article-title":"Viral quasispecies and fitness variations","author":"Domingo","year":"1999"},{"key":"10.1016\/j.virusres.2007.12.021_bib42","first-page":"51","article-title":"Viruses as quasispecies: biological implications","volume":"299","author":"Domingo","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2007.12.021_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/viro.2001.0920","article-title":"Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants","volume":"285","author":"Dykes","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib44","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/JCM.02415-05","article-title":"Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture","volume":"44","author":"Dykes","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virusres.2007.12.021_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00623322","article-title":"Selforganization of matter and the evolution of biological macromolecules","volume":"58","author":"Eigen","year":"1971","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.virusres.2007.12.021_bib46","series-title":"The Hypercycle: A Principle of Natural Self-Organization","author":"Eigen","year":"1979"},{"key":"10.1016\/j.virusres.2007.12.021_bib47","doi-asserted-by":"crossref","first-page":"9737","DOI":"10.1021\/bi9600308","article-title":"A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation","volume":"35","author":"Fan","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.virusres.2007.12.021_bib48","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1143767","article-title":"A whole-genome association study of major determinants for host control of HIV-1","volume":"317","author":"Fellay","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.virusres.2007.12.021_bib49","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/JVI.01594-06","article-title":"Fitness landscape of human immunodeficiency virus type 1 protease quasispecies","volume":"81","author":"Fern\u00e1ndez","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/QAD.0b013e3280187505","article-title":"Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations","volume":"21","author":"Frankel","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib51","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/JVI.74.14.6262-6268.2000","article-title":"Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection","volume":"74","author":"Frost","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib52","first-page":"138","article-title":"Antiretroviral drug resistance and resistance testing","volume":"13","author":"Gallant","year":"2005","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib53","first-page":"556","article-title":"The M184V mutation: what it does, how to prevent it, and what to do with it when it's there","volume":"16","author":"Gallant","year":"2006","journal-title":"AIDS Read"},{"key":"10.1016\/j.virusres.2007.12.021_bib54","first-page":"92","article-title":"Drug resistance is associated with impaired protease and reverse transcriptase function and reduced replication capacity: characterization of recombinant viruses derived from 200 HIV-1 infected patients","volume":"5","author":"Gamarnik","year":"2000","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib55","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1128\/JVI.74.20.9339-9346.2000","article-title":"Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1","volume":"74","author":"Garc\u00eda-Lerma","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib56","doi-asserted-by":"crossref","first-page":"13907","DOI":"10.1073\/pnas.241300698","article-title":"Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons","volume":"98","author":"Garc\u00eda-Lerma","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2007.12.021_bib57","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1128\/JVI.78.14.7545-7552.2004","article-title":"Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q\/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine","volume":"78","author":"Garc\u00eda-Lerma","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.virol.2005.09.005","article-title":"Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure","volume":"344","author":"Gatanaga","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib59","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1128\/JVI.73.7.5803-5813.1999","article-title":"The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5\u2019-end- and DNA 3\u2019-end-directed RNase H activities","volume":"73","author":"Gerondelis","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib60","first-page":"319","article-title":"In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected patients","volume":"28","author":"Gianotti","year":"2005","journal-title":"New Microbiol."},{"key":"10.1016\/j.virusres.2007.12.021_bib61","series-title":"Viral Fitness: The Next SARS and West Nile in the Making","author":"Goudsmit","year":"2004"},{"key":"10.1016\/j.virusres.2007.12.021_bib62","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1128\/jvi.70.8.5662-5664.1996","article-title":"Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase","volume":"70","author":"Goudsmit","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib63","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1128\/jvi.71.6.4479-4484.1997","article-title":"Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215","volume":"71","author":"Goudsmit","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib64","first-page":"S41","article-title":"Transmission of drug resistant HIV-1 exhibiting lower replication capacity is associated with higher CD4 cell counts","volume":"7","author":"Grant","year":"2002","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib65","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1128\/jvi.66.12.7128-7135.1992","article-title":"Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2\u2032,3\u2032-dideoxyinosine and 2\u2032,3\u2032-dideoxycytidine","volume":"66","author":"Gu","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib66","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1128\/jvi.70.9.5930-5934.1996","article-title":"Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility","volume":"70","author":"Harrigan","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib67","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/JVI.72.5.3773-3778.1998","article-title":"Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro","volume":"72","author":"Harrigan","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib68","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/315317","article-title":"Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy","volume":"181","author":"Harrigan","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib69","first-page":"S101","article-title":"Replication Capacity as a predictor of immunological and virological benefit despite virologic failure of an antiretroviral regimen","volume":"7","author":"Haubrich","year":"2002","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib70","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1128\/jvi.70.11.7894-7899.1996","article-title":"Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients","volume":"70","author":"Havlir","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00013","article-title":"Host determinants in HIV infection and disease. Part 1. Cellular and humoral immune responses","volume":"134","author":"Hogan","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib72","doi-asserted-by":"crossref","first-page":"978","DOI":"10.7326\/0003-4819-134-10-200105150-00012","article-title":"Host determinants in HIV infection and disease. Part 2. Genetic factors and implications for antiretroviral therapeutics","volume":"134","author":"Hogan","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib73","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/jvi.65.6.2960-2967.1991","article-title":"Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses","volume":"65","author":"Holland","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib74","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(03)15018-0","article-title":"Change to abacavir-lamivudine-tenofovir combination treatment in patients with HIV-1 who had complete virological suppression","volume":"362","author":"Hoogewerf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2007.12.021_bib75","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1128\/JVI.02747-05","article-title":"Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1","volume":"80","author":"Hu","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib76","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/QAI.0b013e31806ada48","article-title":"Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase","volume":"45","author":"Hu","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2007.12.021_bib77","first-page":"S60","article-title":"Reverse transcriptase mutations that confer non-nucleoside reverse transcriptase inhibitor resistance may also impair replication capacity","volume":"7","author":"Huang","year":"2002","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib78","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/JVI.77.2.1512-1523.2003","article-title":"Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication","volume":"77","author":"Huang","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib79","first-page":"S113","article-title":"Compensatory fixation explains long term persistence of the M41L in HIV-1 reverse transcriptase in a large transmission cluster","volume":"11","author":"Huigen","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib80","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.virol.2007.03.028","article-title":"Evolution of a novel 5-amino-acid insertion in the \u03b23-\u03b24 loop of HIV-1 reverse transcriptase","volume":"364","author":"Huigen","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1099\/0022-1317-83-1-93","article-title":"In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants","volume":"83","author":"Iglesias-Ussel","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib82","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1128\/JVI.74.23.10958-10964.2000","article-title":"Relative replication fitness of a high-level 3\u2032-azido-3\u2032-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr\u2192Gly) at codon 69","volume":"74","author":"Imamichi","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib83","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/JVI.75.8.3988-3992.2001","article-title":"Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles","volume":"75","author":"Imamichi","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib84","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/jvi.70.2.1086-1090.1996","article-title":"Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy","volume":"70","author":"Iversen","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib85","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2001.0888","article-title":"Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect","volume":"283","author":"Jeeninga","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib86","first-page":"119","article-title":"Update of the drug resistance mutations in HIV-1: 2007","volume":"15","author":"Johnson","year":"2007","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib87","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.48.1.172-175.2004","article-title":"Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs","volume":"48","author":"Joly","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib88","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1128\/JVI.79.14.9026-9037.2005","article-title":"Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions","volume":"79","author":"Joos","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2004.01.004","article-title":"Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis","volume":"322","author":"Julias","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib90","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1128\/JVI.77.12.6743-6752.2003","article-title":"Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene","volume":"77","author":"Karlsson","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib91","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1073\/pnas.89.5.1934","article-title":"Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine","volume":"89","author":"Kellam","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2007.12.021_bib92","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/jvi.71.4.3346-3350.1997","article-title":"Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase","volume":"71","author":"Keulen","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib93","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1128\/JVI.73.7.5356-5363.1999","article-title":"Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay","volume":"73","author":"Kosalaraksa","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib94","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virol.2006.05.021","article-title":"Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V","volume":"353","author":"Koval","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib95","doi-asserted-by":"crossref","first-page":"13485","DOI":"10.1073\/pnas.251559398","article-title":"A fossil record of zidovudine resistance in transmitted isolates of HIV-1","volume":"98","author":"Kuritzkes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2007.12.021_bib96","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1099\/0022-1317-75-5-951","article-title":"Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase","volume":"75","author":"Larder","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib97","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.43.8.1961","article-title":"A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance","volume":"43","author":"Larder","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00126334-200501010-00007","article-title":"Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine","volume":"38","author":"Lecossier","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2007.12.021_bib99","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/367989","article-title":"Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population","volume":"187","author":"Leigh Brown","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib100","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/AAC.45.7.2144-2146.2001","article-title":"Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine","volume":"45","author":"Lennerstrand","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002030-200101260-00006","article-title":"Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes","volume":"15","author":"Liegler","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib102","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV","volume":"347","author":"Little","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib103","first-page":"S129","article-title":"Persistence of transmitted drug-resistant virus among subjects with primary HIV infection deferring antiretroviral therapy","volume":"7","author":"Little","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib104","unstructured":"Little, S., Frost, S., Smith, D., May, S., Parkin, N., Richman, D., 2007. Transmission of HIV drug resistance and treatment response (Abstract 60). In: Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections, February 25\u201328, 2007. Los Angeles, CA, USA, http:\/\/www.retroconference.org\/2007\/Abstracts\/30598.htm."},{"key":"10.1016\/j.virusres.2007.12.021_bib105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa062876","article-title":"Response to antiretroviral therapy after a single, peripartum dose of nevirapine","volume":"356","author":"Lockman","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00126334-200105010-00002","article-title":"A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants","volume":"27","author":"Lu","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2007.12.021_bib107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.qai.0000172369.82456.36","article-title":"Effect of the Q207D mutation in HIV type 1 reverse transcriptase on zidovudine susceptibility and replicative fitness","volume":"40","author":"Lu","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2007.12.021_bib108","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/088922201750252007","article-title":"Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs","volume":"17","author":"Lukashov","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2007.12.021_bib109","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/515282","article-title":"Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance","volume":"177","author":"Maeda","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib110","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1128\/JVI.74.18.8524-8531.2000","article-title":"Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug","volume":"74","author":"Mammano","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib111","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1128\/JVI.74.23.11067-11072.2000","article-title":"Estimating relative fitness in viral competition experiments","volume":"74","author":"Maree","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib112","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1128\/AAC.00816-06","article-title":"In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine","volume":"50","author":"Margot","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib113","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/JVI.79.11.7121-7134.2005","article-title":"Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry","volume":"79","author":"Marozsan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib114","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/COH.0b013e328011a1f4","article-title":"Risk of selecting resistance mutations during treatment interruption","volume":"2","author":"Martinez-Picado","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib115","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/JCM.37.9.2943-2951.1999","article-title":"Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing","volume":"37","author":"Martinez-Picado","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virusres.2007.12.021_bib116","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00002030-200204120-00009","article-title":"Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions","volume":"16","author":"Martinez-Picado","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib117","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1093\/emboj\/19.21.5752","article-title":"Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance","volume":"19","author":"Mas","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.virusres.2007.12.021_bib118","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/AAC.45.6.1836-1842.2001","article-title":"Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors","volume":"45","author":"Masquelier","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib119","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.qai.0000186361.42834.61","article-title":"Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003","volume":"40","author":"Masquelier","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2007.12.021_bib120","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00002030-200305230-00003","article-title":"Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants","volume":"17","author":"Matsumi","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib121","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0165-6147(02)02054-0","article-title":"Targeting HIV: antiretroviral therapy and development of drug resistance","volume":"23","author":"Men\u00e9ndez-Arias","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.virusres.2007.12.021_bib122","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virusres.2007.12.015","article-title":"Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase","volume":"134","author":"Men\u00e9ndez-Arias","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.virusres.2007.12.021_bib123","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2174\/138161206776873608","article-title":"Insertions and deletions in HIV-1 reverse transcriptase: consequences for drug resistance and viral fitness","volume":"12","author":"Men\u00e9ndez-Arias","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.virusres.2007.12.021_bib124","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002030-200001280-00012","article-title":"HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitor during abacavir monotherapy and combination therapy","volume":"14","author":"Miller","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/mol.54.2.291","article-title":"Human immunodeficiency virus type 1 reverse transcriptase expressing the K70E mutation exhibits a decrease in specific activity and processivity","volume":"54","author":"Miller","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.virusres.2007.12.021_bib126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/314560","article-title":"Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro","volume":"179","author":"Miller","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib127","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1069660","article-title":"Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level","volume":"296","author":"Moore","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.virusres.2007.12.021_bib128","series-title":"Introduction to Theoretical Population Genetics","author":"Nagylaki","year":"1992"},{"key":"10.1016\/j.virusres.2007.12.021_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.10269","article-title":"Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy","volume":"69","author":"Nicastri","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1073\/pnas.0609642104","article-title":"Mutations in the connection domain of HIV-1 reverse transcriptase increase 3\u2032-azido-3\u2032-deoxythymidine resistance","volume":"104","author":"Nikolenko","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2007.12.021_bib131","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1128\/JVI.00083-07","article-title":"Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment","volume":"81","author":"Nora","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib132","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2004.04.010","article-title":"Tryptophan scanning mutagenesis of aromatic residues within the polymerase domain of HIV-1 reverse transcriptase: critical role of Phe-130 for p51 function and second-site revertant restoring viral replication capacity","volume":"324","author":"Olivares","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib133","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jmb.2007.06.073","article-title":"HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions","volume":"372","author":"Olivares","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virusres.2007.12.021_bib134","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1128\/jvi.70.6.3698-3705.1996","volume":"70","author":"Olmsted","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jmv.20557","article-title":"The contribution of HIV fitness to the evolution pattern of reverse transcriptase inhibitor resistance","volume":"78","author":"Paintsil","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib136","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/molbev\/msl168","article-title":"HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions","volume":"24","author":"Parera","year":"2007","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.virusres.2007.12.021_bib137","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/08892220151126580","article-title":"Primary and recombinant hiv type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues","volume":"17","author":"Penn","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2007.12.021_bib138","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"Perelson","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.virusres.2007.12.021_bib139","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.1128\/JVI.75.20.9644-9653.2001","article-title":"Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein","volume":"75","author":"Peters","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib140","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1128\/AAC.48.11.4189-4194.2004","article-title":"Differential maintenance of the M184V substitution in the reverse transcriptase of human immunodeficiency virus type 1 by various nucleoside antiretroviral agents in tissue culture","volume":"48","author":"Petrella","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib141","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/AAC.44.4.920-928.2000","article-title":"A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1","volume":"44","author":"Petropoulos","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib142","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2004.06.006","article-title":"Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215","volume":"326","author":"Prado","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib143","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/432619","article-title":"HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure","volume":"41","author":"Prado","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib144","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1368-7646(02)00123-1","article-title":"Fitness of drug resistant HIV-1: methodology and clinical implications","volume":"5","author":"Qui\u00f1ones-Mateu","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.virusres.2007.12.021_bib145","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1128\/JVI.74.19.9222-9233.2000","article-title":"A dual infection\/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression","volume":"74","author":"Qui\u00f1ones-Mateu","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib146","doi-asserted-by":"crossref","first-page":"10546","DOI":"10.1128\/JVI.76.20.10546-10552.2002","article-title":"Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation","volume":"76","author":"Qui\u00f1ones-Mateu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib147","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1128\/JVI.77.16.9069-9073.2003","article-title":"Role of the human immunodeficiency virus type 1 envelope gene in viral fitness","volume":"77","author":"Rangel","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib148","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/viro.1997.8620","article-title":"Population dynamics studies of wild-type and drug-resistant mutant HIV in mixed infections","volume":"236","author":"Rayner","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib149","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2007.12.021_bib150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1096\/fasebj.12.9.625","article-title":"Influence of host genes on HIV-1 disease progression","volume":"12","author":"Roger","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.virusres.2007.12.021_bib151","first-page":"290","article-title":"The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy","volume":"2","author":"Ross","year":"1999","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib152","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/171.6.1411","article-title":"Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)","volume":"171","author":"Schuurman","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2007.12.021_bib153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/135965350300800209","article-title":"Nucleotide analogue binding, catalysis and primer unblocking in the mechanisms of HIV-1 reverse transcriptase-mediated resistance to nucleoside analogues","volume":"8","author":"Selmi","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib154","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.40.12.2887","article-title":"Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors","volume":"40","author":"Shafer","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib155","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1128\/jvi.71.11.8846-8851.1997","article-title":"Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation","volume":"71","author":"Sharma","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib156","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.1128\/JVI.73.10.8448-8456.1999","article-title":"Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val","volume":"73","author":"Sharma","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib157","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1073\/pnas.92.6.2398","article-title":"Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides","volume":"92","author":"Shirasaka","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2007.12.021_bib158","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1128\/JVI.77.14.7736-7745.2003","article-title":"Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection","volume":"77","author":"Simon","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib159","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.1716788","article-title":"Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase","volume":"253","author":"St. Clair","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.virusres.2007.12.021_bib160","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/89090","article-title":"Impaired replication of protease inhibitor-resistant HIV-1 in human thymus","volume":"7","author":"Stoddart","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2007.12.021_bib161","first-page":"146","article-title":"Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors","volume":"2","author":"Sugiura","year":"1999","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib162","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1089\/088922201750461366","article-title":"Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine","volume":"17","author":"Suzuki","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2007.12.021_bib163","doi-asserted-by":"crossref","first-page":"D117","DOI":"10.2741\/957","article-title":"Retroviral mutation rates and reverse transcriptase fidelity","volume":"8","author":"Svarovskaia","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.virusres.2007.12.021_bib164","doi-asserted-by":"crossref","unstructured":"Svarovskaia, E., Feng, J., Margot, N., Myrick, F., Goodman, D., Ly, J., White, K., Borroto-Esoda, K., Miller, M., 2007. The A62V and S68G mutations in HIV-1 reverse transcriptase partially restore the replication defect associated with the K65R mutation (Abstract 591). In: Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections, February 25\u201328, 2007. Los Angeles, CA, USA, http:\/\/www.retroconference.org\/2007\/Abstracts\/30039.htm.","DOI":"10.1097\/QAI.0b013e31817bbe93"},{"key":"10.1016\/j.virusres.2007.12.021_bib165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jmv.10246","article-title":"Persistence of earlier HIV-1 drug resistance mutations at new treatment failure","volume":"68","author":"Svedhem","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib166","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1128\/JVI.02084-05","article-title":"Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors","volume":"80","author":"Svicher","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib167","doi-asserted-by":"crossref","first-page":"F161","DOI":"10.1097\/00002030-199814000-00003","article-title":"Stable rearrangements of the \u03b23-\u03b24 hairpin loop of HIV-1 reverse transcriptase in plasma viruses from patients receiving combination therapy","volume":"12","author":"Tamalet","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib168","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/AAC.41.5.1094","article-title":"Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89","volume":"41","author":"Tisdale","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib169","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1128\/JVI.79.14.9006-9018.2005","article-title":"Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression","volume":"79","author":"Troyer","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib170","first-page":"17","article-title":"HIV transmission and primary drug resistance","volume":"8","author":"Turner","year":"2006","journal-title":"AIDS Rev."},{"key":"10.1016\/j.virusres.2007.12.021_bib171","first-page":"S143","article-title":"Decreased rates of transmission of drug-resistant HIV-1 strains containing the M184V mutation in reverse transcriptase","volume":"7","author":"Turner","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib172","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1128\/JVI.79.6.3536-3543.2005","article-title":"Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase","volume":"79","author":"van der Hoek","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib173","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jviromet.2005.11.008","article-title":"A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and\/or reverse transcriptase variants","volume":"133","author":"van Maarseveen","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2007.12.021_bib174","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.44.8.2109-2117.2000","article-title":"Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues","volume":"44","author":"Van Vaerenbergh","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib175","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JVI.02135-06","article-title":"Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region","volume":"81","author":"Villena","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib176","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.virol.2006.01.014","volume":"348","author":"Wang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib177","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1099\/vir.0.19123-0","article-title":"A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy","volume":"84","author":"Weber","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib178","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1128\/JCM.43.3.1395-1400.2005","article-title":"Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation","volume":"43","author":"Weber","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virusres.2007.12.021_bib179","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jviromet.2006.04.004","article-title":"Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness","volume":"136","author":"Weber","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2007.12.021_bib180","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/00002030-200212060-00003","article-title":"The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses","volume":"16","author":"Wei","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2007.12.021_bib181","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2007.12.021_bib182","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0042-6822(03)00173-9","article-title":"Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis","volume":"311","author":"Wei","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2007.12.021_bib183","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.46.11.3437-3446.2002","article-title":"Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity","volume":"46","author":"White","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2007.12.021_bib184","doi-asserted-by":"crossref","first-page":"8958","DOI":"10.1128\/JVI.76.17.8958-8962.2002","article-title":"The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus","volume":"76","author":"Whitney","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib185","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI4948","article-title":"A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors","volume":"102","author":"Winters","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virusres.2007.12.021_bib186","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1128\/JVI.74.22.10707-10713.2000","article-title":"Genotypic, phenotypic, and modeling studies of a deletion in the \u03b23-\u03b24 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors","volume":"74","author":"Winters","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib187","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JVI.80.5.2380-2389.2006","article-title":"Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib188","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1128\/JVI.72.5.3520-3523.1998","article-title":"Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants","volume":"72","author":"Yerly","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2007.12.021_bib189","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/135965350400900312","article-title":"Infrequent transmission of HIV-1 drug-resistant variants","volume":"9","author":"Yerly","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2007.12.021_bib190","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1128\/AAC.43.10.2479","article-title":"In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues","volume":"43","author":"Yoshimura","year":"1999","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020800004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020800004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:01:16Z","timestamp":1759154476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016817020800004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":190,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S016817020800004X"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2007.12.021","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2007.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}